Effective Dec. 31, 2021, NC Medicaid will end several of the temporary COVID-19 rate increases. Some of the rate increases in effect in December 2021 will be extended – at either current or revised levels - through Jan. 31, 2022.
Blog Entry List
In order to ensure optimal access to care for NC Medicaid beneficiaries and to support providers during the recent COVID-19 surge, NC Medicaid is extending the Hospital at Home program through March 31, 2022.
The NC Medicaid Electronic Health Record (EHR) Incentive Program is no longer accepting Program Year 2021 attestations.
The seven-part series covers current policies and procedures under the new NC Medicaid Managed Care guidelines.
Standard Plans temporarily extended minimum appeal timeframes to support the transition to NC Medicaid Managed Care.
The Food and Drug Administration and the Advisory Committee on Immunization Practices have authorized COVID-19 boosters for all adults (18 years and older).
The Pre-Admission Screening and Resident Review application has changed its website domain address.
NC Medicaid has extended its deadline to February 2022 to send the renewed waiver application to the Centers for Medicare and Medicaid Services to request approval of the CAP/C waiver for another five years.
The December 2021 NC Medicaid Personal Care Services Public Health Emergency Uniform rates previously released in Special Bulletin COVID-19 #194 are being revised effective Dec. 1, 2021.
NC Medicaid is extending all current COVID-19 temporary provider rate increases through Dec. 31, 2021.
A provider enrollment fee must be collected from Medicaid and NC Health Choice providers initially enrolling in, or revalidating their enrollment in, Medicare, Medicaid or NC Health Choice, or adding a new Medicare practice location.
The National Committee for Quality Assurance (NCQA) has developed a Kidney Health Toolkit to assist in bringing awareness to diabetes.
Billing guidelines for PADP when billed with HCPCS code J3490.
Effective with date of service Aug. 23, 2021, the Medicaid and NC Health Choice programs cover pneumococcal 20-valent conjugate vaccine for use in the PADP when billed with HCPCS code 90677.
Effective with date of service Sept. 22, 2021, the Medicaid and NC Health Choice programs cover tisotumab vedotin-tftv for use in the PADP when billed with HCPCS code J9999.